Clinical trial
Specific Use Results Survey of LENVIMA 4 mg Capsules -Observational Study of Overall Survival in Patients With Unresectable Hepatocellular Carcinoma (Study LEN03T)
NCT04008082 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Specific Use Results Survey of LENVIMA 4 mg Capsules -Observational Study of Overall Survival in Patients With Unresectable Hepatocellular Carcinoma (Study LEN03T)
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 14, 2019
- Completion date
- January 28, 2022
- Enrollment
- 412 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.